Tofacitinib in Vitiligo: Case Series and Open-Label Studies ± NB-UVB

September 11, 2025 | vitiligo

Key Takeaways Tofacitinib (JAK1/3 inhibitor) has shown facial repigmentation in multiple case series; responses improve with concurrent light (NB-UVB or […]